ATE404185T1 - Medizinische aerosolformulierungen mit verbesserter chemischer stabilität - Google Patents

Medizinische aerosolformulierungen mit verbesserter chemischer stabilität

Info

Publication number
ATE404185T1
ATE404185T1 AT05715569T AT05715569T ATE404185T1 AT E404185 T1 ATE404185 T1 AT E404185T1 AT 05715569 T AT05715569 T AT 05715569T AT 05715569 T AT05715569 T AT 05715569T AT E404185 T1 ATE404185 T1 AT E404185T1
Authority
AT
Austria
Prior art keywords
chemical stability
improved chemical
linking agent
butyl rubber
cross
Prior art date
Application number
AT05715569T
Other languages
English (en)
Inventor
Brian Meakin
David Lewis
Robert Johnson
Tanya Church
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of ATE404185T1 publication Critical patent/ATE404185T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
AT05715569T 2004-05-13 2005-02-25 Medizinische aerosolformulierungen mit verbesserter chemischer stabilität ATE404185T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04011425 2004-05-13

Publications (1)

Publication Number Publication Date
ATE404185T1 true ATE404185T1 (de) 2008-08-15

Family

ID=34960892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05715569T ATE404185T1 (de) 2004-05-13 2005-02-25 Medizinische aerosolformulierungen mit verbesserter chemischer stabilität

Country Status (19)

Country Link
US (1) US20070086953A1 (de)
EP (1) EP1746981B1 (de)
JP (1) JP2007537170A (de)
KR (1) KR20070010159A (de)
CN (1) CN1950075A (de)
AT (1) ATE404185T1 (de)
AU (1) AU2005245248A1 (de)
BR (1) BRPI0510852A (de)
CA (1) CA2565747A1 (de)
DE (1) DE602005008946D1 (de)
EA (1) EA200602112A1 (de)
ES (1) ES2309722T3 (de)
IL (1) IL178739A0 (de)
MA (1) MA28649B1 (de)
MX (1) MXPA06013189A (de)
NO (1) NO20065722L (de)
TN (1) TNSN06334A1 (de)
WO (1) WO2005112902A2 (de)
ZA (1) ZA200608742B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20186870B (en) * 2013-12-30 2018-06-25 Chiesi Farma Spa Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
HUE039513T2 (hu) * 2013-12-30 2019-01-28 Chiesi Farm Spa Glikopirrónium-bromid és formoterol kombinációját tartalmazó nyomás alatti stabil aeroszol oldatkészítmény
CN106620976B (zh) * 2016-12-28 2020-01-07 四川普锐特医药科技有限责任公司 一种丙酸氟替卡松定量吸入气雾剂
GB202001537D0 (en) 2020-02-05 2020-03-18 Consort Medical Plc Pressurised dispensing container
MX2023003754A (es) * 2020-10-09 2023-04-24 Chiesi Farm Spa Formulacion farmaceutica para inhalador presurizado de dosis medidas.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
EE05167B1 (et) * 2000-05-22 2009-06-15 Chiesi Farmaceutici S.P.A. Stabiilsed farmatseutilised lahuspreparaadid survestatud doseerivatele inhalaatoritele
DK3384931T3 (da) * 2002-03-01 2019-09-16 Chiesi Farm Spa Superfin formoterolformulering
US20040126325A1 (en) * 2002-03-12 2004-07-01 David Lewis Medicinal aerosol solution formulation products with improved chemical stability
US7736712B2 (en) * 2002-03-18 2010-06-15 Consort Medical Plc Seal material for a dispensing apparatus
EP1595531A1 (de) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stabile Arzneimittellösung für Druckdosierinhalatoren
IL177103A0 (en) * 2004-02-27 2006-12-10 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurized metered dose inhalers
KR101313959B1 (ko) * 2005-02-25 2013-10-02 키에시 파르마슈티시 엣스. 피. 에이. 금속이온 봉쇄제로 구성되는 압축계량된 도스 흡입기용약제 에어로졸 조성물

Also Published As

Publication number Publication date
EP1746981B1 (de) 2008-08-13
WO2005112902A2 (en) 2005-12-01
KR20070010159A (ko) 2007-01-22
TNSN06334A1 (en) 2008-02-22
US20070086953A1 (en) 2007-04-19
BRPI0510852A (pt) 2007-11-27
ES2309722T3 (es) 2008-12-16
AU2005245248A1 (en) 2005-12-01
NO20065722L (no) 2006-12-12
EA200602112A1 (ru) 2007-04-27
CA2565747A1 (en) 2005-12-01
IL178739A0 (en) 2007-02-11
DE602005008946D1 (de) 2008-09-25
JP2007537170A (ja) 2007-12-20
MA28649B1 (fr) 2007-06-01
EP1746981A2 (de) 2007-01-31
MXPA06013189A (es) 2007-02-14
WO2005112902A3 (en) 2006-05-04
ZA200608742B (en) 2008-07-30
CN1950075A (zh) 2007-04-18

Similar Documents

Publication Publication Date Title
ES2618829T3 (es) Sello para un aparato dispensador
DK0616525T3 (da) Medikamenter
PE20011323A1 (es) Formulaciones farmaceuticas en solucion estable para inhaladores presurizados con medicion de dosis
ATE471144T1 (de) Intranasale verabreichung von schnell wirkendem insulin
DE60308997D1 (de) Formulierungen zur inhalation
AR059350A1 (es) Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva
HRP20050822A2 (en) Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
BR0112322A (pt) Nova formulação aerossol contendo uma molécula fluorada polar
AU2024219491B2 (en) Pressurised dispensing container
BR0208363A (pt) Produtos de formulação de solução aerossol medicinal com estabilidade quìmica melhorada
MY143075A (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers.
ATE404185T1 (de) Medizinische aerosolformulierungen mit verbesserter chemischer stabilität
DE60310899T2 (de) Dichtungsmaterial für eine spenderapparatur
WO2007020204A3 (en) Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
BR112012008983A2 (pt) "formulação medicinal em suspensão, composição farmacêutica, produto, uso de cromolina sódica,e, método para aumentar a estabilidade de uma formulação medicinal em suspensão de aerossol."
WO2017021698A1 (en) Seal for a dispensing apparatus
BRPI0408003A (pt) produtos antiperspirante/desodorizante em aerossol
WO2004103339A3 (en) Improved metered dose inhaler
BRPI0405842B8 (pt) composição farmacêutica estabilizada de composto flúor-éter para uso anestésico. método para estabilizar um composto flúor-éter. uso de agente estabilizante para impedir a degradação de composto flúor éter.
BR0012907A (pt) Agente para o remédio de dano neural, composto contendo nitrogênio, e, composição farmacêutica
GB2445483A (en) Seal for a pharmaceutical dispensing device

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties